Relationship of histologic grade and histologic subtype with oncotype Dx recurrence scoreI3/4 retrospective review of 863 breast cancer oncotype Dx results

被引:36
作者
Singh, Kamaljeet [1 ]
He, Xin [2 ]
Kalife, Elizabeth T. [1 ]
Ehdaivand, Shahrzad [1 ]
Wang, Yihong [3 ]
Sung, C. James [1 ]
机构
[1] Brown Univ, Alpert Med Sch, Women & Infants Hosp, Dept Pathol & Lab Med, 101 Dudley St, Providence, RI 02903 USA
[2] Rhode Isl Hosp, Providence, RI 02903 USA
[3] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Pathol & Lab Med, 593 Eddy St, Providence, RI 02903 USA
关键词
Breast cancer; Prognosis; Survival; Genetics; Chemotherapy; Recurrence score; Ductal carcinoma; Lobular carcinoma; INVASIVE LOBULAR CARCINOMA; CLINICOPATHOLOGICAL DATA; PREDICTION; ASSAY; INTERMEDIATE; CHEMOTHERAPY; PROGNOSIS; TAMOXIFEN; UTILITY; INDEX;
D O I
10.1007/s10549-017-4619-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncotype Dx (ODx) is a multigene assay that is prognostic and predictive in estrogen receptor (ER) positive early breast cancer. ODx recurrence score (RS) is reported to be histologic grade dependent. Relationship of RS with breast cancer histologic subtypes is unknown. This study was designed to assess the relationship of histologic subtype with RS. Histologic grade dependence of RS was also investigated. Results of consecutive ODx tests (1/2007-7/2016) from two institutions were reviewed. Histologic subtypes (in: Lakhani et al., WHO classification, IARC Press, Lyon, 2012), combined Nottingham histologic grade, age and tumor size were recorded from pathology reports. Univariate and multivariate analysis was performed to investigate the relationship between RS and ODx risk categories and histologic subtypes, grade, age and tumor size. RS was grade dependent. RS of grade 1 and grade 2 tumors were significantly lower than grade 3 tumors. There was no high-risk grade 1 tumor. In favorable histologic subtypes there was no high-risk tumor. Mean RS of grade 1 lobular tumors was significantly higher than grade 1 ductal tumors. Using newer ODx cut-offs, 5 grade 1 tumors were reclassified as high risk (RS > 25) and grade 3 lobular tumors showed significantly higher rate of reclassification as high-risk than grade 3 ductal tumors. In a multivariate analysis, only grade showed a significant positive correlation with RS. Adding dichotomous histologic subtyping (favorable vs. non-favorable) to grade further improved correlation with RS. The Oncotype Dx result is impacted by histologic grade and histologic subtype. Tumors with favorable histologic subtypes and histologic grade 1 tumors do not have high-risk RS. High RS in a grade 1 tumor or in a tumor with favorable histology is unusual that warrants further investigation. Invasive lobular carcinomas rarely show high-risk RS. Histologic grade and histologic subtype should be considered while ordering ODx testing.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 28 条
[1]   A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas [J].
Acs, Geza ;
Esposito, Nicole N. ;
Kiluk, John ;
Loftus, Loretta ;
Laronga, Christine .
MODERN PATHOLOGY, 2012, 25 (04) :556-566
[2]   Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing? [J].
Allison, K. H. ;
Kandalaft, P. L. ;
Sitlani, C. M. ;
Dintzis, S. M. ;
Gown, A. M. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) :413-424
[3]   Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma [J].
Bomeisl, Philip E. ;
Thompson, Cheryl L. ;
Harris, Lyndsay N. ;
Gilmore, Hannah L. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) :1546-1549
[4]   Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma? [J].
Conlon, Niamh ;
Ross, Dara S. ;
Howard, Jane ;
Catalano, Jeffrey P. ;
Dickler, Maura N. ;
Tan, Lee K. .
BREAST JOURNAL, 2015, 21 (05) :514-519
[5]  
Cotter MB, 2017, VIRCHOWS ARCH
[6]   An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer [J].
Felts, Jesse L. ;
Zhu, Junjia ;
Han, Bing ;
Smith, Stanley J. ;
Truica, Cristina I. .
BREAST JOURNAL, 2017, 23 (06) :677-686
[7]   Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer [J].
Fisher, B ;
Dignam, J ;
Wolmark, N ;
DeCillis, A ;
Emir, B ;
Wickerham, DL ;
Bryant, J ;
Dimitrov, NV ;
Abramson, N ;
Atkins, JN ;
Shibata, H ;
Deschenes, L ;
Margolese, RG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22) :1673-1682
[8]   Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes [J].
Fisher, B ;
Dignam, J ;
Tan-Chiu, E ;
Anderson, S ;
Fisher, ER ;
Wittliff, JL ;
Wolmark, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (02) :112-120
[9]   Histopathologic variables predict Oncotype DX™ Recurrence Score [J].
Flanagan, Melina B. ;
Dabbs, David J. ;
Brufsky, Adam M. ;
Beriwal, Sushil ;
Bhargava, Rohit .
MODERN PATHOLOGY, 2008, 21 (10) :1255-1261
[10]   The Oncotype DX Recurrence Score Is Correlated With a Composite Index Including Routinely Reported Pathobiologic Features [J].
Geradts, Joseph ;
Bean, Sarah M. ;
Bentley, Rex C. ;
Barry, William T. .
CANCER INVESTIGATION, 2010, 28 (09) :969-977